Research Article
Wharton’s Jelly Mesenchymal Stem Cell Administration Improves Quality of Life and Self-Sufficiency in Children with Cerebral Palsy: Results from a Retrospective Study
Table 8
Treatment efficacy in subgroups identified on the basis of improvement in quality of life after the first WJ-MSC administration.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Improvement in quality of life (QoL) after first administration. The highest improvement in QoL between two consecutive assessments. Cells marked in bold represent categorization used in Yates’ chi-square test. |